Literature DB >> 31652115

Detoxifying Action of Aqueous Extracts of Mucuna pruriens Seed and Mimosa pudica Root Against Venoms of Naja nigricollis and Bitis arietans.

Matthew P Ameh1, Mamman Mohammed1, Yusuf P Ofemile1, Magaji G Mohammed2, Ada Gabriel1, Akefe O Isaac3.   

Abstract

BACKGROUND: The World Health Organization included snakebite envenomation among Neglected Tropical Diseases in 2017. The importance of natural products from plants is enormous, given that most prescribed drugs originate from plants. Among this is Mucuna pruriens and Mimosa pudica, with many registered patents asserting their health benefits.
OBJECTIVE: This study investigated the in vitro neutralizing effects of Mucuna pruriens seed and Mimosa pudica root extracts on venoms of Naja nigricollis and Bitis arietans.
METHODS: In mice, the LD50 and phytochemical analysis of M. pruriens and M. pudica plant extracts were carried out prior to the evaluation of their haemolytic and fibrinolytic effect. Their effects on the activities of phospholipase A2 (PLA2) were also assessed.
RESULTS: At a concentration of 50 mg/ml, both plant extracts were found to neutralize the fibrinolytic activity of N. nigricollis, but 400 mg/ml was required to neutralize the fibrinolytic activity of B. arietans. In haemolytic studies, 50 mg/ml concentration of M. pruriens extract suppressed haemolysis caused by N. nigricollis venom by 70% but at the same concentration, M. pudica extract reduced haemolysis by 49.4%. M. pruriens, at 50 mg/ml concentration, only inhibited phospholipase A2 activity by 7.7% but higher concentrations up to 400mg/ml had no effect against the venom of N. nigricollis; at 200 mg/ml. M. pudica extract inhibited PLA2 activity by 23%.
CONCLUSION: The results suggest that M. pruriens and M. pudica may be considered as promising antivenom agents for people living in a snake-bite prone environment. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Bitis arietans; Mimosa pudica; Mucuna pruriens; Naja nigricollis; Snakes; antivenom; in vitro; venom.

Mesh:

Substances:

Year:  2020        PMID: 31652115     DOI: 10.2174/1872208313666191025110019

Source DB:  PubMed          Journal:  Recent Pat Biotechnol        ISSN: 1872-2083


  5 in total

1.  Anthelmintic activity of methanol extract of Dennettia tripetala G. Baker (Annonaceae) fruits against Haemonchus contortus in red Sokoto goats.

Authors:  Rachel A Nwosu; Mohammed M Suleiman; Hussaina J Makun; Matthew P Ameh; Manji A Shetshak; Isaac O Akefe
Journal:  Trop Anim Health Prod       Date:  2021-12-08       Impact factor: 1.559

2.  In vitro anthelmintic activity of Dennettia tripetala G. Baker (Annonaceae) Fruits against Haemonchus contortus.

Authors:  Rachel A Nwosu; Mohammed M Suleiman; Hussaina J Makun; Matthew P Ameh; Manji A Shetshak; Isaac O Akefe
Journal:  J Parasit Dis       Date:  2021-08-17

3.  Flavonoid fractions of diosmin and hesperidin mitigate lead acetate-induced biochemical, oxidative stress, and histopathological alterations in Wistar rats.

Authors:  Ibrahim Yusuf Lamidi; Hudu Garba Mikail; Sani Adamu; Isaac Oluwatobi Akefe; Mohammed Bashir Tijjani; Sabo Isa Salihu; Aisha Omobolanle Olatunji; Abdussalam Hassan; Nubwa Daniel; Victoria Aderonke Adegoke
Journal:  Toxicol Res       Date:  2021-04-29

Review 4.  Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective.

Authors:  Sachchida Nand Rai; Vivek K Chaturvedi; Payal Singh; Brijesh Kumar Singh; M P Singh
Journal:  3 Biotech       Date:  2020-11-10       Impact factor: 2.406

5.  Novel Pomegranate-Nanoparticles Ameliorate Cisplatin-Induced Nephrotoxicity and Improves Cisplatin Anti-Cancer Efficacy in Ehrlich Carcinoma Mice Model.

Authors:  Steve Harakeh; Mohammed S Almuhayawi; Isaac O Akefe; Saber H Saber; Soad K Al Jaouni; Torki Alzughaibi; Yousef Almehmadi; Soad Shaker Ali; Dhruba J Bharali; Shaker Mousa
Journal:  Molecules       Date:  2022-02-28       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.